Medicare in 2026 and 2027: A System Under Compounding Pressure

Medicare is no longer approaching a fiscal reckoning — it is inside one. The 2026 Medicare Trustees report, released on June 9, 2026, delivers a verdict that is unambiguous: the program is on an unsustainable course, and the window for orderly reform is narrowing with each passing year. Total Medicare spending reached more than $1.2 trillion in the most recent full year. The Trustees project it will cost nearly $19 trillion over the next decade. Simultaneously, the One Big Beautiful Bill Act has accelerated the timeline for trust fund depletion while cutting over $1 trillion from health programs broadly — the largest rollback of federal health care support in American history.

What follows is a structured review of the program's current financial condition, the specific pressures building in 2026 and 2027, and the legislative and structural forces that will determine whether Medicare emerges from this decade intact.

The Trust Fund Timeline: 2033, and Closer Than It Looks

The Medicare Hospital Insurance (HI) Part A Trust Fund is now projected to reach insolvency in the second quarter of 2033 — one quarter earlier than projected in last year's report. This is the fund that pays for inpatient hospital stays, skilled nursing facility care, hospice, and several post-acute care services. It is financed primarily through dedicated Medicare payroll taxes. When it runs dry, the program will be able to reimburse providers only 89 cents for every dollar of Part A services provided.

Critically, the Trustees report that expenditures will begin to exceed trust fund income as early as 2027. The reserves of the fund — $255.7 billion as of 2026 — will erode steadily over the next seven years. The 2033 insolvency date is not a cliff edge; it is the end of a long, visible decline that begins this year.

To achieve fiscal balance over the 75-year window, policymakers would have needed to reduce scheduled benefits starting in January 2026 by 12%, or increase the Medicare payroll tax from 2.90% to 3.46% — a 19% increase. If action is deferred until 2033, the required adjustments will be substantially larger and concentrated into a far shorter window.

The HI actuarial deficit has widened from 0.42% to 0.56% of taxable payroll in a single year. The 75-year unfunded obligation for Part A alone stands at $4.2 trillion. These are not projections to be revised away; they reflect structural demographic and fiscal realities that compound annually.

Part B and Part D: The Bigger and Faster-Growing Problem

The focus on HI trust fund insolvency, while warranted, obscures a more immediately pressing reality: Part B and Part D spending is larger, faster-growing, and directly translates into higher costs for beneficiaries and taxpayers every single year. Part B spending — covering physician services, hospital outpatient care, and durable medical equipment — reached $584 billion recently, dwarfing Part A's $444 billion. Part B premiums jumped by nearly 10% in 2026 to $202.90 per month, exceeding $200 for the first time in the program's history.

The Trustees project Part B expenditures will grow 52% as a share of GDP over the next decade. Part D prescription drug expenditures will grow nearly 12% as a share of GDP over the same period, driven in significant part by surging utilization of GLP-1 medications and high-cost specialty drugs. The Supplementary Medical Insurance (SMI) trust fund that covers Parts B and D cannot technically become insolvent — it is automatically refinanced each year through general revenues and beneficiary premiums — but this structural feature simply means the cost is transferred directly to the federal deficit and to beneficiaries' monthly bills.

By 2050, the combined average premiums and cost-sharing that beneficiaries pay for Parts B and D are projected to consume more than one-third of the average Social Security benefit, up from approximately one-quarter today. This is the quiet tax on retirement that no headline captures.

The 2027 Inflection: When Spending Formally Exceeds Income

The year 2027 represents a formal inflection point. Beginning in 2027, spending on Part A services will exceed the HI trust fund's income for the first time, initiating the drawdown of reserves. This is not a catastrophic event in isolation, but it marks the transition from a program that is building reserves to one that is consuming them. The cost rate — the ratio of expenditures to payroll tax income — stood at 3.37% recently, will reach 3.49% by end of 2026, and is projected to climb to 4.58% by 2050.

For Medicare Advantage, 2027 is also a year of significant policy transition. The Centers for Medicare and Medicaid Services (CMS) is expected to propose changes to MA payments, oversight structures, and Star Ratings methodology. MA now covers 51% of all Medicare beneficiaries — up from 34% in 2017 — and is projected to reach 56% by 2035. Over the next decade, MA alone will account for more than $9 trillion of Medicare's total spending. Yet the program currently costs Medicare approximately 14% more per enrollee than traditional fee-for-service, translating into $76 billion in additional spending in 2026 alone. Coding intensity and favorable selection into MA plans are responsible for much of this premium, and MedPAC estimates that this overpayment is adding approximately $11 billion per year to beneficiary Part B premiums.

The One Big Beautiful Bill: Accelerating the Clock

The One Big Beautiful Bill Act (H.R. 1) has materially altered Medicare's fiscal trajectory. The legislation permanently extends lower income tax rates and expands the standard deduction, including a new temporary deduction for taxpayers over age 65. This reduces income taxes paid on Social Security benefits, which are a dedicated revenue source for the Part A Trust Fund — a direct hit to HI income that the 2026 Trustees report explicitly identifies as a driver of the worsened depletion timeline.

The law also limits Medicare's ability to negotiate drug prices by carving out orphan drugs from the negotiation process established under the Inflation Reduction Act. It imposes a nine-year ban on implementing improvements to Medicare Savings Programs (MSPs), which help lower-income beneficiaries pay for premiums and cost-sharing. The Congressional Budget Office estimates this MSP freeze will generate $66 billion in savings over 10 years — savings that come directly from preventing eligible beneficiaries from accessing assistance they qualify for.

Additionally, starting in January 2027, the Social Security Administration must terminate Medicare coverage for lawfully present immigrants who do not meet newly restricted eligibility criteria. This includes refugees, asylum seekers, individuals with Temporary Protected Status, and survivors of trafficking and domestic violence — populations that in many cases have worked and paid Medicare payroll taxes for years. The full scope of this enrollment contraction will become visible in 2027 enrollment data.

The Aging Population: Where the Spending Is Accelerating Fastest

The demographic driver underlying all of these projections is the continued aging of the baby boomer generation into Medicare. The program now covers approximately 70 million Americans. The Trustees project that Part A expenditure growth over the next decade will be most rapid for services associated with frail and elderly beneficiaries: inpatient hospital services (4.8% annual growth), skilled nursing facilities (7.0%), home health (7.3%), hospice (8.9%), and hospital outpatient services in Part B (over 8.0%).

The shift from inpatient to outpatient settings is itself a structural trend that is accelerating costs in Part B. As procedures migrate from hospital inpatient to outpatient settings, they move from Part A financing to Part B financing — from a trust fund with a hard depletion date to one that is automatically refinanced through general revenues and beneficiary premiums. The fiscal pressure does not disappear; it transfers.

What Reform Actually Requires

The Bipartisan Policy Center, the Committee for a Responsible Federal Budget, and Georgetown's Center on Health Insurance Reforms have each outlined the range of interventions that could stabilize the program. The options are not new, but the urgency is. They include reducing overpayments to Medicare Advantage plans, expanding Medicare's drug price negotiation authority, restructuring the benefit design of Medicare fee-for-service, adjusting the payroll tax rate, modifying eligibility criteria, and moving certain services between trust funds to better align financing with cost growth.

None of these options is painless. Each involves a transfer of cost or risk — to beneficiaries, to providers, to taxpayers, or to the federal balance sheet. The question is not whether the transfer will occur, but whether it will be managed deliberately through policy or imposed abruptly through insolvency. Congress has historically intervened before HI trust fund depletion. But the 2026 legislative environment, shaped by the OBBB's revenue reductions and the political difficulty of benefit reform, makes the path to a comprehensive solution narrower than it has been in decades.

For beneficiaries, the immediate reality is a program that is more expensive today than it was a year ago, with higher Part B premiums, higher cost-sharing, and fewer protections for lower-income enrollees. For taxpayers, it is a program consuming an ever-larger share of general revenues with no structural mechanism to contain that growth. For policymakers, it is a seven-year window before the most visible deadline arrives — and a far shorter window before the political and fiscal costs of inaction become irreversible.